Tag Archives: BRCA2

Supreme Court hears arguments on case with far-reaching implications for genetic research

The much-contested question of whether or not a gene can be patented is under judicial scrutiny once again. The U.S. Supreme Court listened to oral arguments today regarding Myriad Genetic’s patent of two genes, BRCA1 and BRCA2, which have been linked to increased cancer risk in both women and men.  The American Civil Liberties Union is challenging this patent on behalf of a group of researchers, medical groups and patients. The timing of the hearing is rather serendipitous, just one day after the 10th anniversary of the completion of the Human Genome Project. The Human Genome Project, a jointly funded venture from the Department of Energy and the National Institutes of Health, has opened the door to a wide array of genetic tests and targeted interventions. Continue reading →

Advertisements